Nov 11 (Reuters) - Genetic testing firm 23andMe
said on Monday it is reducing its overall headcount by over 200
employees or about 40% of the workforce, as part of a
restructuring program.
The company expects annualized cost savings of more than $35
million as a result of the restructuring.